Page 70 - Nse Nifty

IRFC up 4% as centre elevates company's status to Navratna from Miniratna I

Under the Navratna central public sector enterprises (CPSEs) status IRFC can invest up to Rs 1,000 crore or 15 per cent of their net worth in a single project

Experts see Nifty 22,000 as key support; DIIs long bets highest in 1 year

Key takeaways from F&O data: Substantial PUT accumulation at the Nifty 22,000 strike solidifies this level as a reliable support base, says Dhupesh Dhameja of SAMCO Securities.

Mastek hits 52-week low after Sebi issues warning letter; Check details

The warning letter was for not identifying a transaction as Unpublished Price Sensitive Information (UPSI) involving acquisition of a US-based entity by a subsidiary of the company in the US

Teamlease slips 5% as Goldman Sachs sells over 0.2 mn shares via bulk deals

As per National Stock Exchange (NSE) bulk deal data, Goldman Sachs Funds - Goldman Sachs India Equity Portfolio sold 1,67,802 shares at Rs 1,865 per share and 89,314 shares at Rs 1,960 per share

IndusInd Bank down 4% as Integrated Core sells 5 mn shares via bulk deal

As per National Stock Exchange (NSE) bulk deal data, Integrated Core Strategies (Asia) Pte sold 50,86,943 shares for Rs 986.74 per share through a bulk deal

Why One 97 Communications, parent of Paytm, shares lost 4% in trade today?

The company has allegedly violated the Foreign Exchange Management Act (Fema) involving aggregate transactions worth over Rs 611 crore related to the acquisition of its subsidiaries

Sensex chart flags new worries, may test 72,000; levels to track this week

Market outlook for the week March 03 - 07, 2025: Here are the key weekly support and resistance levels on the BSE Sensex and the NSE Nifty 50 index.

Dr. Agarwal's Health Care shares slip 5% after 30-day anchor lock-in ends

An anchor lock-in refers to an investor being "locked" into a particular stock or investment due to a psychological or financial bias that makes them reluctant to sell or switch investments

Can Nifty fall 20% from peak to enter bear phase? Chart check

Analysts believe the market may not enter bear territory for now; instead expect some time-wise correction and sectoral rotation going ahead. Here are the key levels to track.

Patanjali Foods down 11% in trade today; here's what's worrying investors

Around 10:35 AM, Patanjali share price was down 9.56 per cent at Rs 1,639.7 per share on BSE. In comparison, the BSE Sensex was down 1.19 per cent at 73,727.81

Granules down 7% after USFDA issues warning letter or Gagillapur facility

"On February 26, 2025, the US FDA issued a Warning Letter to Granules' Gagillapur facility based on its inspection conducted in August 2024," the filing read

FIIs start March F&O series with short bets in Nifty, Bank Nifty futures

Key takeaways from F&O data: FIIs bearish; retail, DIIs hold bullish bets in index futures. Nifty, Bank Nifty options data indicates a bearish stance in the market.

Indian markets can rise 15% in a year; FII selling surprised me: Chris Wood

Speaking at BS Manthan, Wood said he remains structurally bullish on Indian equities from a long-term perspective; but cautious in the short-term given the quantum of FII outflows and valuation woes.

Nifty monthly losing streak 2nd worst in 30 yrs; why you should be worried

The Nifty 50 index has shed nearly 13% in the last five straight months, its longest losing streak since November 1996; equalling its second-worst ever in the 30-year history.

Nestle shares rise 2% after reports suggests company is mulling price hikes

"Wherever (price increase) is absolutely essential, we will have to take some pricing action," Nestle India Managing Director Suresh Narayanan told Reuters

Bharti Airtel rises 3% on partnering with Ericsson for 5G Core technology

As per the filing, the collaboration will enable Airtel to seamlessly transition to a commercially live, full-scale 5G standalone network over time, bringing the high-end capabilities of 5G

Venus Remedies up 4% after entering license agreement with UK-based Infex

The agreement authorises Venus Remedies to spearhead the clinical development, registration, and commercialisation of MET-X, an innovative metallo-beta- lactamase (MBL) inhibitor

Zaggle shares up 3% on inking agreement with Mamaearth parent Honasa

Under the contract, the Zaggle will provide Honasa Consumer with services from Zaggle Zoyer Platform which helps businesses streamline and automate multi-branch and store recurring expenses

Welspun Specialty hits 5% upper circuit; here's what's boosting rally

Welspun Specialty Solutions will offer 13,25,22,289 rights equity shares for an amount aggregating to Rs 349.86 crore.

FIIs may not return to India soon; China remains a better bet: Analysts

Indian investors will have to be patient as FII inflows are not expected in the short to medium term. However, long-term view is intact